A phase II, double-blind, randomised, placebo-controlled study of BMS945429 (ALD518) in patients with rheumatoid arthritis with an inadequate response to methotrexate

Mease, P ; Strand, V ; Shalamberidze, L ; Dimic, A ; Raskina, T ; Xu, Li-An ; Liu, Y ; Smith, J

Annals of the rheumatic diseases, 2012-07, Vol.71 (7), p.1183-1189 [Periódico revisado por pares]

London: BMJ Publishing Group Ltd and European League Against Rheumatism

Texto completo disponível